Natixis’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-119,942
| Closed | -$7.66M | – | 1179 |
|
|
2025
Q4 | $7.66M | Buy |
119,942
+87,970
| +275% | +$5.42M | 0.03% | 385 |
|
|
2025
Q3 | $2.02M | Sell |
31,972
-11,334
| -26% | -$791K | 0.01% | 569 |
|
|
2025
Q2 | $3.23M | Buy |
+43,306
| New | +$3.4M | 0.01% | 416 |
|
|
2025
Q1 | – | Sell |
-25,014
| Closed | -$2.28M | – | 1039 |
|
|
2024
Q4 | $2.28M | Buy |
25,014
+12,619
| +102% | +$1.29M | 0.01% | 451 |
|
|
2024
Q3 | $1.39M | Sell |
12,395
-263
| -2% | -$26.3K | 0.01% | 479 |
|
|
2024
Q2 | $1.24M | Sell |
12,658
-13,021
| -51% | -$1.29M | 0.01% | 483 |
|
|
2024
Q1 | $2.57M | Buy |
25,679
+20,791
| +425% | +$1.83M | 0.01% | 405 |
|
|
2023
Q4 | $439K | Buy |
4,888
+2,979
| +156% | +$237K | ﹤0.01% | 636 |
|
|
2023
Q3 | $146K | Buy |
1,909
+368
| +24% | +$30.5K | ﹤0.01% | 746 |
|
|
2023
Q2 | $129K | Sell |
1,541
-118,718
| -99% | -$9.65M | ﹤0.01% | 777 |
|
|
2023
Q1 | $10.1M | Buy |
120,259
+117,112
| +3,721% | +$10.1M | 0.09% | 185 |
|
|
2022
Q4 | $256K | Sell |
3,147
-452,101
| -99% | -$36.4M | ﹤0.01% | 793 |
|
|
2022
Q3 | $32.8M | Buy |
455,248
+2,649
| +0.6% | +$238K | 0.15% | 102 |
|
|
2022
Q2 | $40.8M | Buy |
+452,599
| New | +$46.9M | 0.15% | 91 |
|
|
2022
Q1 | – | Sell |
-31,066
| Closed | -$3.76M | – | 1206 |
|
|
2021
Q4 | $3.76M | Buy |
31,066
+22,877
| +279% | +$2.54M | 0.01% | 625 |
|
|
2021
Q3 | $825K | Sell |
8,189
-19,770
| -71% | -$2.18M | ﹤0.01% | 928 |
|
|
2021
Q2 | $3.26M | Buy |
27,959
+18,580
| +198% | +$2.23M | 0.01% | 452 |
|
|
2021
Q1 | $1.03M | Buy |
+9,379
| New | +$1.02M | ﹤0.01% | 825 |
|
|
2020
Q4 | – | Sell |
-3,444
| Closed | -$269K | – | 1050 |
|
|
2020
Q3 | $269K | Buy |
+3,444
| New | +$260K | ﹤0.01% | 672 |
|
|
2020
Q2 | – | Sell |
-12,049
| Closed | -$561K | – | 770 |
|
|
2020
Q1 | $561K | Sell |
12,049
-90,939
| -88% | -$5.84M | ﹤0.01% | 560 |
|
|
2019
Q4 | $8.07M | Buy |
102,988
+28,785
| +39% | +$2.21M | 0.05% | 323 |
|
|
2019
Q3 | $5.48M | Buy |
74,203
+67,548
| +1,015% | +$4.85M | 0.04% | 341 |
|
|
2019
Q2 | $518K | Sell |
6,655
-88,000
| -93% | -$6.69M | ﹤0.01% | 607 |
|
|
2019
Q1 | $7.18M | Buy |
94,655
+25,353
| +37% | +$2.02M | 0.05% | 323 |
|
|
2018
Q4 | $5.07M | Sell |
69,302
-21,784
| -24% | -$1.74M | 0.04% | 320 |
|
|
2018
Q3 | $8.72M | Buy |
91,086
+22,684
| +33% | +$2.25M | 0.05% | 297 |
|
|
2018
Q2 | $6.84M | Buy |
68,402
+27,124
| +66% | +$2.86M | 0.04% | 341 |
|
|
2018
Q1 | $4.36M | Buy |
+41,278
| New | +$4.17M | 0.03% | 383 |
|
|
2017
Q4 | – | Sell |
-3,716
| Closed | -$336K | – | 928 |
|
|
2017
Q3 | $336K | Buy |
+3,716
| New | +$316K | ﹤0.01% | 852 |
|
|
2017
Q2 | – | Sell |
-15,109
| Closed | -$1.22M | – | 864 |
|
|
2017
Q1 | $1.22M | Sell |
15,109
-6,672
| -31% | -$525K | 0.02% | 371 |
|
|
2016
Q4 | $1.64M | Buy |
+21,781
| New | +$1.57M | 0.02% | 384 |
|
|
2015
Q2 | – | Sell |
-3,044
| Closed | -$211K | – | 392 |
|
|
2015
Q1 | $211K | Buy |
+3,044
| New | +$220K | ﹤0.01% | 400 |
|
|
2014
Q2 | – | Sell |
-140,000
| Closed | -$12.1M | – | 476 |
|
|
2014
Q1 | $12.1M | Hold |
140,000
| – | – | 0.16% | 125 |
|
|
2013
Q4 | $11.3M | Sell |
140,000
-5,713
| -4% | -$444K | 0.1% | 167 |
|
|
2013
Q3 | $11.4M | Buy |
+145,713
| New | +$11.2M | 0.12% | 169 |
|
Other funds holding EMN
VPM
VCM
Natixis's EMN Position: Q1 2026 in Review
Natixis sold out of Eastman Chemical (EMN) in Q1 2026, closing a stake of 119,942 shares — an estimated $7.66M sold.
Natixis first reported a position in EMN in Q3 2013 and held it in 35 quarters. The position peaked at $40.8M in Q2 2022. 637 funds tracked by Wall St. Rank hold EMN as of Q1 2026.
- Natixis reported no remaining Eastman Chemical position as of Q1 2026 after selling out during the quarter.
- Natixis sold 119,942 Eastman Chemical shares in Q1 2026, an estimated $7.66M.
- Natixis first reported a position in Eastman Chemical in Q3 2013 and held it in 35 quarters.
- Natixis's Eastman Chemical position peaked at $40.8M in Q2 2022.
- 637 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.